July 23, 2017 1:29 AM ET


Company Overview of Gamida Cell Ltd.

Company Overview

Gamida Cell Ltd. develops stem cell population expansion technologies and stem cell therapy products for transplantation and regenerative medicine. The company offers its products for treating a range of conditions, including blood cancers, such as leukemia, lymphoma, and solid tumors; autoimmune diseases; and non-malignant hematological diseases, such as sickle cell disease and thalassemia, neutropenia, acute radiation syndrome, and metabolic diseases. Its products include StemEx, a stem cell therapy product that addresses an unmet clinical need for patients with hematological malignancies; NiCord, a graft of stem/progenitor cells for hematological, autoimmune, and metabolic diseases; CordB...

Nahum Hafzadi 5 Street

Givat Shaul

Jerusalem,  95464


Founded in 1998


972 2 659 5666


972 2 659 5616

Key Executives for Gamida Cell Ltd.

Chief Executive Officer, President and Director
Co-Founder, Chief Scientific Officer and Vice President of Research & Development
Chief Financial Officer
Head of the Stem Cell Consortium Projects
Age: 55
Chief Medical Officer
Compensation as of Fiscal Year 2017.

Gamida Cell Ltd. Key Developments

Gamida Cell Inc. Names Ronit Simantov, M.D. as Chief Medical Officer

Gamida Cell announced that Ronit Simantov, M.D. will join the company as its new Chief Medical Officer (CMO) based in the U.S. Prior to joining Gamida Cell, Dr. Simantov was Vice President and Head of Global Medical Affairs at Pfizer Oncology. Previous roles included Vice President, Head of Clinical Development at OSI Pharmaceuticals, Chief Medical Officer at CuraGen Corporation, and Global Clinical Leader in Oncology at Bayer HealthCare Pharmaceuticals.

Gamida Cell Ltd. Announces $40 Million Private Financing

Gamida Cell Ltd. announced the signing of a $40 million financing to support the ongoing Phase 3 trial of the company's FDA Breakthrough Designated clinical-stage product, NiCord, to facilitate bone marrow transplantation. The financing is being led by new investor Shavit Capital. Additional primary participants include new investors VMS Investment Group and Israel Biotech Fund, as well as existing investor and major shareholder, Novartis. Current shareholders Clal Biotechnology Industries (CBI) and Israel HealthCare Ventures (IHCV) also participated in the financing. Gamida Cell plans to use the proceeds to complete NiCord's Phase 3 clinical trial and prepare for product commercialization by expanding its in-house manufacturing capacity, and the Company's presence in the US, as well as continuing to develop additional pipeline products such as CordIn ® for rare genetic diseases and NK cells as a treatment for cancer.

Gamida Cell Announces Appointments to its Board of Directors

Gamida Cell announced the appointment of Nobel Prize Laureate Professor Roger Kornberg and immune oncology expert and recently retired Novartis executive Dr. Michael Perry to its Board of Directors. Dr. Michael Perry recently retired from Novartis, following a highly successful tenure where he served as SVP and Chief Scientific Officer, Global BD&L, Chief Scientific Officer, Cell & Gene Therapy Unit, Global Head, Cellular Therapy/VP, Integrated Hospital Care Franchise and as Novartis' observer on the Gamida Cell Board of Directors.

Similar Private Companies By Industry

Company Name Region
3PLW Ltd. Middle East/Africa
Accelerated Evolution Biotechnologies Ltd Middle East/Africa
Adante Ltd. Middle East/Africa
Advanced Biotechnology Ltd. Middle East/Africa
Advanced Medical Analysis (AMA) Ltd. Middle East/Africa

Recent Private Companies Transactions

Private Placement
June 19, 2017
March 5, 2017

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
The Advertising Council, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Gamida Cell Ltd., please visit www.gamida-cell.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.